Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 2
2011 1
2014 2
2015 2
2016 1
2017 1
2018 2
2021 10
2022 10
2023 12
2024 12
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9. Lancet. 2021. PMID: 34767764 Free article. Clinical Trial.
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.
Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Giménez AI, Hinze C, McCann LJ, Reed AM, Rider LG, Arvigo M, Bader-Meunier B, Bruno C, Caifeng L, Campanilho-Marques R, Cuccato S, Fiorillo C, Hahn NA, Huber AM, Jansen M, Kasapcopur O, Katsikas MM, Kim S, Livermore P, Maillard S, Malattia C, Migowa AN, Miyamae T, Murphy R, Nicolai R, Papadopoulou C, Pilkington C, Sanner H, Sawhney S, Smolewska E, Tarvin SE, Tiller G, Toplak N, Wedderburn LR, Bovis F, Consolaro A, Feldman BM. Ravelli A, et al. Among authors: tarvin se. Ann Rheum Dis. 2025 Jul;84(7):1055-1067. doi: 10.1016/j.ard.2025.04.024. Epub 2025 May 22. Ann Rheum Dis. 2025. PMID: 40410052
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.
Saper VE, Tian L, Verstegen RHJ, Conrad CK, Cidon M, Hopper RK, Kuo CS, Osoegawa K, Baszis K, Bingham CA, Ferguson I, Hahn T, Horne A, Isupova EA, Jones JT, Kasapcopur Ö, Klein-Gitelman MS, Kostik MM, Ozen S, Phadke O, Prahalad S, Randell RL, Sener S, Stingl C, Abdul-Aziz R, Akoghlanian S, Al Julandani D, Alvarez MB, Bader-Meunier B, Balay-Dustrude EE, Balboni I, Baxter SK, Berard RA, Bhattad S, Bolaria R, Boneparth A, Cassidy EA, Co DO, Collins KP, Dancey P, Dickinson AM, Edelheit BS, Espada G, Flanagan ER, Imundo LF, Jindal AK, Kim HA, Klaus G, Lake C, Lapin WB, Lawson EF, Marmor I, Mombourquette J, Ogunjimi B, Olveda R, Ombrello MJ, Onel K, Poholek C, Ramanan AV, Ravelli A, Reinhardt A, Robinson AD, Rouster-Stevens K, Saad N, Schneider R, Selmanovic V, Sefic Pasic I, Shenoi S, Shilo NR, Soep JB, Sura A, Taber SF, Tesher M, Tibaldi J, Torok KS, Tsin CM, Vasquez-Canizares N, Villacis Nunez DS, Way EE, Whitehead B, Zemel LS, Sharma S, Fernández-Viña MA, Mellins ED; CARRA Registry Investigators. Saper VE, et al. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2996-3013.e7. doi: 10.1016/j.jaip.2024.07.002. Epub 2024 Aug 15. J Allergy Clin Immunol Pract. 2024. PMID: 39002722 Free PMC article.
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C; Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup. Tarvin SE, et al. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539. doi: 10.1002/acr.25393. Epub 2024 Aug 14. Arthritis Care Res (Hoboken). 2024. PMID: 38937134
Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis.
Yi BY, Wahezi DM, Covert L, Ardalan K, Hui-Yuen J, Vasquez-Canizares N, Mosa DM, Jones M, Correll C, Begezda A, Shenoi S, Wu EY, Kovalick LK, Lapin WB, Tarvin SE, Oliver MS, Rodriguez MM, Marmor I, Baszis KW, Taxter AJ, Hanson AC, Crowson CS, Orandi AB; CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee. Yi BY, et al. Among authors: tarvin se. Clin Exp Rheumatol. 2025 Jul 25:10.55563/clinexprheumatol/35pbbq. doi: 10.55563/clinexprheumatol/35pbbq. Online ahead of print. Clin Exp Rheumatol. 2025. PMID: 40737048 Free PMC article.
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C; CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party. Sherman MA, et al. Among authors: tarvin se. Rheumatology (Oxford). 2025 Aug 1;64(8):4732-4737. doi: 10.1093/rheumatology/keaf086. Rheumatology (Oxford). 2025. PMID: 39928372 Free PMC article.
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Ogbu EA, Brunner HI, Eloseily E, Aviel YB, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Wahezi DM, Tarvin SE, Sproles A, Chen C, Ruperto N, Huang B, Grom A, Thornton S; Investigators of the PRINTO and PRCSG Networks. Ogbu EA, et al. Among authors: tarvin se. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1723-1732. doi: 10.1002/acr.25417. Epub 2024 Sep 17. Arthritis Care Res (Hoboken). 2024. PMID: 39135452 Free PMC article.
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Lovell DJ, Tzaribachev N, Henrickson M, Simonini G, Griffin TA, Alexeeva E, Bohnsack JF, Zeft A, Horneff G, Vehe RK, Staņēviča V, Tarvin S, Trachana M, Del Río AQ, Huber AM, Kietz D, Orbán I, Dare J, Foeldvari I, Quartier P, Dominique A, Simon TA, Martini A, Brunner HI, Ruperto N; for PRINTO and the Pediatric Rheumatology Collaborative Study Group (PRCSG)§. Lovell DJ, et al. Among authors: tarvin s. Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI195-SI206. doi: 10.1093/rheumatology/keae025. Rheumatology (Oxford). 2024. PMID: 38243722 Free PMC article.
Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome.
Toor KK, Chen A, Cabral DA, Mammen C, Bosman ES, Shen Y, Bone JN, Noone D, Al-Abadi E, Benseler S, Berard R, Bohm M, Charuvanij S, Cook K, Dancey P, Deepak S, Duffy C, Eberhard B, Elder M, Foell D, Gerstbacher D, Heshin-Bekenstein M, Huber A, James KE, Kim S, Klein-Gitelman M, Martin N, McErlane F, Moorthy LN, Myrup C, Riley P, Shenoi S, Sivaraman V, Tanner T, Tarvin S, Wagner-Weiner L, Yeung RSM, Brown KL, Morishita KA; PedVas Investigators Network. Toor KK, et al. Among authors: tarvin s. Arthritis Rheumatol. 2025 May;77(5):606-614. doi: 10.1002/art.43071. Epub 2025 Jan 14. Arthritis Rheumatol. 2025. PMID: 39624015 Free PMC article.
59 results